BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...

Commissions do not affect our editors' opinions or evaluations. BMO—formerly known as BMO Harris Bank—traces its roots back to Canada’s first bank, the Montreal Bank, established in 1817.

The investment in advanced capabilities is at the core of BMO's Digital First strategy to deliver progress and outcomes at scale by merging human expertise with cutting edge technology.

BMO’s prime rate was lowered to 5.25% on January 30, 2025, following the Bank of Canada rate announcement. BMO’s prime rate is the basis for its variable-rate lending products, like mortgages ...

Detailed price information for Bank of Montreal (BMO-T) from The Globe and Mail including charting and trades.